Fresenius SE & Co. KGaA (FRA:FREA)

Market Cap	26.12B
Revenue (ttm)	22.45B
Net Income (ttm)	1.14B
Shares Out	n/a
EPS (ttm)	2.03
PE Ratio	22.85
Forward PE	12.65
Dividend	0.17 (1.44%)
Ex-Dividend Date	May 27, 2025

Volume	n/a
Average Volume	18
Open	11.50
Previous Close	11.50
Day's Range	11.50 - 11.50
52-Week Range	8.10 - 20.00
Beta	n/a
RSI	45.22
Earnings Date	Nov 5, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1912
• Employees: 176,486
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FREA